Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer
暂无分享,去创建一个
[1] J. Guillaume,et al. [PubMed]. , 2020, Annales de dermatologie et de venereologie.
[2] M. Cascella,et al. Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update , 2016, International Journal of Gynecologic Cancer.
[3] Yan Li,et al. Oncologic and reproductive outcomes after fertility‐sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[4] J. Ledermann,et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer , 2015, International Journal of Gynecologic Cancer.
[5] M. Candiani,et al. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. , 2015, Journal of minimally invasive gynecology.
[6] L. Sui,et al. Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women. , 2015, International journal of clinical and experimental medicine.
[7] T. Van den Bosch,et al. Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[8] J. Nam,et al. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. , 2015, The oncologist.
[9] F. Grauso,et al. Surgical Management of Early Endometrial Cancer: An Update and Proposal of a Therapeutic Algorithm , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[10] V. Gebski,et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. , 2014, Contemporary clinical trials.
[11] R. Rouzier,et al. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis. , 2014, Fertility and sterility.
[12] Z. Rosenwaks,et al. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma. , 2014, American journal of obstetrics and gynecology.
[13] V. Šparac,et al. Two cases of successful pregnancies after hysteroscopic removal of endometrioid adenocarcinoma grade I, stage IA, in young women with Lynch syndrome. , 2014, Journal of the Turkish German Gynecological Association.
[14] D. Bae,et al. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study. , 2013, Gynecologic oncology.
[15] B. Yoon,et al. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer. , 2013, American journal of obstetrics and gynecology.
[16] D. Bae,et al. Hormonal Therapy for Women With Stage IA Endometrial Cancer of All Grades , 2013, Obstetrics and gynecology.
[17] R. Zang,et al. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women , 2013, Archives of Gynecology and Obstetrics.
[18] D. Bae,et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). , 2013, European journal of cancer.
[19] J. W. Kim,et al. Pregnancy Outcomes After Fertility-Sparing Management in Young Women With Early Endometrial Cancer , 2013, Obstetrics and gynecology.
[20] A. Coomarasamy,et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. , 2012, American journal of obstetrics and gynecology.
[21] V. Gebski,et al. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. , 2012, Gynecologic oncology.
[22] D. Luton,et al. Progestin treatment of atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium to preserve fertility. , 2012, Anticancer research.
[23] H. Duan,et al. Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysis. , 2011, Fertility and sterility.
[24] A. Agostini,et al. Fertility-sparing management of grade 2 and 3 endometrial adenocarcinomas. , 2011, Anticancer research.
[25] G. Scambia,et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. , 2010, Fertility and sterility.
[26] R. Barakat,et al. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. , 2009, Gynecologic oncology.
[27] E. Bandera,et al. Synchronous Primary Ovarian and Endometrial Cancers: A Population-Based Assessment of Survival , 2009, Obstetrics and gynecology.
[28] R. Broaddus,et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] H. Tsuda,et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] C. Holschneider,et al. Coexisting Ovarian Malignancy in Young Women With Endometrial Cancer , 2005, Obstetrics and gynecology.
[31] M. Segal,et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. , 1999, Radiology.
[32] W T McGivney,et al. The National Comprehensive Cancer Network , 1998, Cancer.
[33] S. Baker,et al. Profile of Women 45 Years of Age and Younger With Endometrial Cancer , 1998, Obstetrics and gynecology.
[34] N. Hacker,et al. Endometrial Cancer in Premenopausal Women 45 Years and Younger , 1995, Obstetrics and gynecology.
[35] M. Dwyer,et al. Genetic/Familial high-risk assessment: Colorectal, version 2.2019 featured updates to the NCCN guidelines , 2019 .
[36] N. Colombo,et al. Special issues in fertility preservation for gynecologic malignancies. , 2016, Critical reviews in oncology/hematology.
[37] Amanda Cipolla,et al. Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature. , 2015, Journal of minimally invasive gynecology.
[38] S. Mabuchi,et al. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature , 2014, Archives of Gynecology and Obstetrics.
[39] J. Dungan. Progestogen treatment options for early endometrial cancer , 2011 .
[40] P. Morice,et al. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. , 2005, Gynecologic oncology.
[41] A. Kaider,et al. Does hysteroscopy facilitate tumor cell dissemination? , 2000, Cancer.